Details for Patent: 5,147,868
✉ Email this page to a colleague
Summary for Patent: 5,147,868
Title: | Thienamycin renal peptidase inhibitors |
Abstract: | Novel chemical compounds are provided which selectively inhibit the metabolism of dipeptidase (E.C.3.4.13.11) and therefore are useful in combination with antibacterial products. These chemical compounds are z-2-acylamino-3-monosubstituted propenoates. |
Inventor(s): | Graham; Donald W. (Mountainside, NJ), Rogers; Edward F. (Middletown, NJ), Kahan; Frederick M. (Scotch Plains, NJ) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 07/839,725 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 5,147,868
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,147,868
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 244550 | ⤷ Try a Trial | |||
Austria | 17472 | ⤷ Try a Trial | |||
Austria | 2299 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |